Brookfield Asset Management Inc. Atri Cure, Inc. Transaction History

Brookfield Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$57.43 - $71.39 $670,552 - $833,549	11,676 Added 60.62%	30,937 $2.03 Million
Q4 2021 Feb 14, 2022	SELL	$63.4 - $87.14 $46,472 - $63,873	-733 Reduced 3.67%	19,261 $1.34 Million
Q3 2021 Nov 16, 2021	BUY	$69.28 - $84.46 $212,066 - $258,532	3,061 Added 18.08%	19,994 $1.39 Million
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $427,299 - $711,548	-12,364 Reduced 42.2%	16,933 $942,000
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $931,058 - $1.5 Million	29,297 New	29,297 $1.32 Million

212

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.85B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.